BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• FDA

  FDA Approves Novartis Corporation’s Reclast(R) to Prevent Osteoporosis in Postmenopausal Women With Convenient Less Frequent Dosing

  June 1, 2009

   · 

  8 min read
• Policy

  ISTA Pharmaceuticals, Inc. Announces FDA Advisory Committee to Review Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis

  June 1, 2009

   · 

  3 min read
• Drug Development

  OXiGENE Reports Positive Data From Phase 2 Trial of ZYBRESTAT in Platinum Resistant Ovarian Cancer At the 2009 American Society of Clinical Oncology Annual Meeting

  June 1, 2009

   · 

  1 min read
• Biotech Bay

  Apieron Inc. Secures Series D Commitments

  June 1, 2009

   · 

  3 min read
• Business

  NxStage Medical, Inc. Extends Supply Agreement with B.Braun Medical to Include Streamline(R) Technology

  June 1, 2009

   · 

  3 min read
• Business

  Micronics Acquires License to Molecular Beacons Technology

  June 1, 2009

   · 

  2 min read
• Business

  Valeritas Announces Appointment of New CEO

  June 1, 2009

   · 

  3 min read
• Deals

  Elan Corporation PLC Shares Up as Bristol-Myers Squibb Company (JOBS) Eyes Stake

  June 1, 2009

   · 

  1 min read
• Policy

  Sepracor, Inc.'s STEDESA(TM) (Eslicarbazepine Acetate) New Drug Application Formally Accepted for Review by the FDA

  June 1, 2009

   · 

  1 min read
• Policy

  ARCA biopharma Receives Complete Response Letter From FDA; FDA Does Not Approve GencaroTM NDA

  June 1, 2009

   · 

  5 min read